Explanation of Sex Differences in Coronary Artery Disease: Finding Nemo? [0.03%]
冠状动脉疾病中性别差异的解释：寻找尼莫？
Leslee J Shaw,Jagat Narula
Leslee J Shaw
Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiological Significance [0.03%]
斑块特性的差异和心肌质量：对生理意义的影响
Chee Hae Kim,Seokhun Yang,Jinlong Zhang et al.
Chee Hae Kim et al.
Background: The mechanism of the fractional flow reserve (FFR) difference according to sex has not been clearly understood. Objectives: ...
Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction [0.03%]
SGLT2抑制剂在射血分数降低的心力衰竭中的全球益处
Nicholas K Brownell,Boback Ziaeian,Gregg C Fonarow
Nicholas K Brownell
Comparison of Contemporary Drug-Eluting Stents in Patients Undergoing Complex High-Risk Indicated Procedures [0.03%]
比较当代药物洗脱支架在进行复杂高风险操作的患者中的应用
Yeong Jin Jeong,Junho Hyun,Junghoon Lee et al.
Yeong Jin Jeong et al.
Background: Limited data are available on the relative performances of diverse contemporary drug-eluting stents (DES) in patients undergoing complex high-risk indicated procedures (CHIP). ...
Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial [0.03%]
两种不同紫杉醇涂层球囊在冠状动脉内支架再狭窄中的比较：随机对照试验
Eun Jung Jun,Eun-Seok Shin,Song Lin Yuan et al.
Eun Jung Jun et al.
Background: Drug-coated balloons (DCBs) offer an effective treatment for in-stent restenosis (ISR). The Genoss DCB is a novel paclitaxel-coated balloon with a shellac plus vitamin E excipient that enhances drug delivery t...
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Valve Stenosis in Chinese Patients [0.03%]
经导管主动脉瓣置换术在低风险中国严重主动脉瓣狭窄患者中的应用
Nanchao Hong,Wenzhi Pan,Shasha Chen et al.
Nanchao Hong et al.
Yun-Dai Chen,Lei Gao
Yun-Dai Chen
Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives [0.03%]
左主冠状动脉疾病的经皮冠状动脉介入治疗：现状和展望
Sangwoo Park,Seung-Jung Park,Duk-Woo Park
Sangwoo Park
For several decades, coronary artery bypass grafting has been regarded as the standard choice of revascularization for significant left main coronary artery (LMCA) disease. However, in conjunction with remarkable advancement of device techn...
Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF [0.03%]
DAPA-HF研究中达格列净对射血分数降低的亚洲心衰患者的影响
Kieran F Docherty,Inder S Anand,Chern-En Chiang et al.
Kieran F Docherty et al.
Background: Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit many differences from those in other parts of the world. Ob...
Differential Clinical Benefit With Contemporary Drug-Eluting Stents: Fact or Fancy? [0.03%]
当代药物洗脱支架的差异性临床疗效：事实还是虚构？
Dean J Kereiakes
Dean J Kereiakes